S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion

OKYO Pharma (OKYO) News Today

GBX 1.40
-0.45 (-24.32%)
(As of 05/19/2023)
SourceHeadline
MarketBeat logoOKYO Pharma (LON:OKYO) Stock Price Down 24.3%
americanbankingnews.com - April 17 at 2:20 AM
msn.com logoA second Kobayashi Pharma Japan factory inspected over deaths
msn.com - March 31 at 1:37 PM
msn.com logoJapanese authorities inspect second Kobayashi Pharma factory after deaths
msn.com - March 31 at 1:37 PM
msn.com logoKobayashi factory searched over deaths possibly linked to supplements
msn.com - March 30 at 3:03 AM
msn.com logo5 dead and over 100 hospitalized from recalled Japanese health supplements
msn.com - March 29 at 4:34 AM
msn.com logoWhat are 'beni-koji' products linked to Japan deaths?
msn.com - March 28 at 3:31 AM
msn.com logoA Japanese supplement pill is recalled after two people died and more than 100 were hospitalized
msn.com - March 27 at 7:29 AM
msn.com logoUnicycive rises 4% on $50M private placement
msn.com - March 14 at 9:33 AM
msn.com logoPeople in Japan more worried about smell of others' excrement than their own: survey
msn.com - March 3 at 1:37 AM
msn.com logo1 in 4 Japan primary school kids with hay fever's itchy eyes have trouble studying
msn.com - February 23 at 7:47 PM
benzinga.com logoOKYO Pharma Stock (NASDAQ:OKYO), Short Interest Report
benzinga.com - February 22 at 12:23 AM
msn.com logoOKYO Pharma gains on receiving FDA nod of IND for OK-101 in neuropathic corneal pain
msn.com - February 9 at 4:03 PM
morningstar.com logoOKYO Shares Rise 12% After FDA Clearance for IND Application
morningstar.com - February 9 at 11:03 AM
markets.businessinsider.com logoOKYO Pharma Says Phase 2 Study Of OK-101 Did Not Meet Primary Goal
markets.businessinsider.com - January 8 at 8:46 AM
finance.yahoo.com logoOKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024
finance.yahoo.com - January 5 at 10:24 AM
proactiveinvestors.com logoEyepoint Pharmaceuticals stock soars on wet-AMD trial results
proactiveinvestors.com - December 4 at 1:00 PM
finance.yahoo.com logoOKYO Pharma Announces Last Patient Enrolled in OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease Has Completed Final Protocol Visit
finance.yahoo.com - December 4 at 7:59 AM
msn.com logoHC Wainwright & Co. Initiates Coverage of OKYO Pharma Limited - (OKYO) with Buy Recommendation
msn.com - November 3 at 1:06 AM
proactiveinvestors.com logoOKYO Pharma raises $5.84m via share issuance
proactiveinvestors.com - October 31 at 12:57 PM
finanznachrichten.de logoOKYO Pharma Announces $5.84 Million Cash Raise and Payables Reduction
finanznachrichten.de - October 31 at 7:31 AM
msn.com logoDry Eye Disease Affects Around 50M Americans, OKYO Pharma's Candidate Shows Safety In Mid-Stage Study
msn.com - October 5 at 2:11 PM
msn.com logoOKYO shares retreat 12% after rallying ahead of Phase 2 study update
msn.com - October 5 at 2:11 PM
markets.businessinsider.com logoOKYO Pharma Reports Positive Safety Data Profile For OK-101 In Dry Eye Disease
markets.businessinsider.com - October 5 at 9:11 AM
proactiveinvestors.com logoOKYO Pharma phase II dry eye trial making encouraging progress
proactiveinvestors.com - October 5 at 9:11 AM
finance.yahoo.com logoOKYO Pharma Announces Positive Safety Data Profile for the ongoing OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease ("DED")
finance.yahoo.com - October 5 at 9:11 AM
proactiveinvestors.com logoOKYO Pharma closes $4M registered direct offering
proactiveinvestors.com - September 15 at 8:38 AM
finance.yahoo.com logoOKYO Pharma Announces Pricing of $4.0 Million Registered Direct Offering of Ordinary Shares
finance.yahoo.com - September 14 at 9:36 AM
uk.finance.yahoo.com logoOKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2 Clinical Trial of OK-101 to treat Dry Eye Disease (“DED”)
uk.finance.yahoo.com - August 30 at 7:28 AM
proactiveinvestors.com logoOKYO Pharma regains compliance with Nasdaq listing minimum...OKYO Pharma regains compliance with Nasdaq listing minimum market...
proactiveinvestors.com - August 29 at 4:17 PM
marketwatch.com logoOKYO Pharma Shares Rise 15% After Regaining Nasdaq Compliance
marketwatch.com - August 29 at 4:17 PM
proactiveinvestors.com logoOKYO Pharma withdraws public offer
proactiveinvestors.com - August 1 at 7:00 PM
marketwatch.com logoStocks to Watch: Barnes & Noble Education, HomeStreet and OKYO Pharma
marketwatch.com - July 28 at 8:08 PM
finance.yahoo.com logoOKYO Pharma Limited Receives Nasdaq Deficiency Notice
finance.yahoo.com - July 28 at 8:08 PM
finance.yahoo.com logoOKYO Pharma Announces Proposed Public Offering of Ordinary Shares
finance.yahoo.com - July 28 at 8:08 PM
benzinga.com logoEye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?
benzinga.com - May 30 at 12:42 PM
finanznachrichten.de logoOKYO Pharma LTD: OKYO Pharma Now Participating on the Webull Corporate Communications Service Platform
finanznachrichten.de - May 11 at 9:50 AM
finance.yahoo.com logoOKYO Pharma Now Participating on the Webull Corporate Communications Service Platform
finance.yahoo.com - May 11 at 9:50 AM
finance.yahoo.com logoGoldman Small Cap Research Publishes New Research Report on OKYO Pharma Limited
finance.yahoo.com - May 9 at 12:43 PM
proactiveinvestors.com logoOKYO Pharma reaches milestone with first patient screening for dry eye disease trial
proactiveinvestors.com - May 2 at 8:14 PM
proactiveinvestors.com logoOKYO Pharma screens first patient for dry eye disease trial
proactiveinvestors.com - May 2 at 10:12 AM
finance.yahoo.com logoOKYO Pharma Announces First-Patient First-Visit for Phase 2 Trial Evaluating Efficacy and Safety of OK-101 in Patients with Dry Eye Disease
finance.yahoo.com - May 2 at 10:12 AM
ca.finance.yahoo.com logoOKYO Pharma Limited (OKYO)
ca.finance.yahoo.com - April 29 at 9:02 AM
benzinga.com logoOKYO Pharma Activates First Clinical Trial Site For Phase 2 Study Of OK-101 To Treat Dry Eye Disease
benzinga.com - April 26 at 10:10 AM
msn.com logoLondon stock market is 'a complete waste of time': Italian biotech tycoon plans to quit the City
msn.com - April 18 at 11:35 PM
benzinga.com logoOKYO Pharma Management Takes Company Stock In Private Placement Instead Of Deferred Pay
benzinga.com - April 18 at 8:33 AM
reuters.com logoFTSE 100 falls as oil stocks drag, pound rises
reuters.com - April 4 at 1:27 PM
finanznachrichten.de logoOKYO Pharma LTD: Notice of Intention to Delist From The London Stock Exchange
finanznachrichten.de - April 4 at 8:26 AM
marketwatch.com logoOkyo Pharma Shares Fall on London Stock Delisting Plan
marketwatch.com - April 4 at 8:26 AM
proactiveinvestors.com logoOKYO Pharma plans UK de-listing in favour of US quote
proactiveinvestors.com - April 4 at 8:26 AM
msn.com logoBanks, miners push FTSE 100 up for seventh day; OKYO Pharma slumps
msn.com - April 4 at 8:26 AM
Get OKYO Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for OKYO and its competitors with MarketBeat's FREE daily newsletter.

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

OKYO Media Mentions By Week

OKYO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OKYO
News Sentiment

0.00

0.51

Average
Medical
News Sentiment

OKYO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OKYO Articles
This Week

1

0

OKYO Articles
Average Week

Get OKYO Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for OKYO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (LON:OKYO) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners